Transcriptional activation of the human HMG1 gene in cisplatin-resistant human cancer cells

Cancer Research

Volumn 61, Issue 4, 2001, Pages 1592-1597

  Nagatani, Gunji ^a   Nomoto, Minoru ^a   Takano, Hiroshi ^a   Ise, Tomoko ^a   Kato, Ken ^a   Imamura, Toshihiro ^a   Izumi, Hiroto ^a   Makishima, Kazumi ^a   Kohno, Kimitoshi ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; HIGH MOBILITY GROUP PROTEIN;

ARTICLE; CANCER CELL; CYTOTOXICITY; DNA ADDUCT; DNA REPAIR; DNA REPLICATION; ELECTROPHORETIC MOBILITY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MOLECULAR CLONING; PRIORITY JOURNAL; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TATA BOX; TRANSCRIPTION REGULATION;

ANTINEOPLASTIC AGENTS; BASE SEQUENCE; CCAAT-ENHANCER-BINDING PROTEINS; CISPLATIN; CLONING, MOLECULAR; CONSENSUS SEQUENCE; DNA FOOTPRINTING; DNA, NEOPLASM; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; HIGH MOBILITY GROUP PROTEINS; HUMANS; KB CELLS; MOLECULAR SEQUENCE DATA; NFI TRANSCRIPTION FACTORS; PROMOTER REGIONS (GENETICS); RNA, MESSENGER; SEQUENCE ANALYSIS, DNA; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS; UP-REGULATION;

EID: 0035866336     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Cisplatin, and DNA repair in cancer chemotherapy
2. Modulation of cisdiamminedichloroplatinum(II) resistance: A review
3. Reduction of drug accumulation in cisplatin-resistant variants of human prostatic cancer PC-3 cell line
4. Adenosine triphosphate-dependent transport of leukotriene C4 by membrane vesicles prepared from cisplatin-resistant human epidermoid carcinoma tumor cells
5. Glutathione-associated enzymes in anticancer drug resistance
6. Overexpression of metallothionein confers resistance to anticancer drugs
7. Cellular levels of thioredoxin associated with drug sensitivity to cisplatin, mitomycin C, doxorubicin, and etoposide
8. Formation and repair of DNA interstrand cross-links in relation to cytotoxicity and unscheduled DNA synthesis induced in control and mutant human cells treated with cis-diamminedichloroplatinum(II)
9. Formation and repair of cisplatin-induced adducts to DNA in cultured normal and repair-deficient human fibroblasts
10. The major chromatin protein histone H1 binds preferentially to cis-platinum-damaged DNA
11. Proteins that specifically recognize cisplatin-damaged DNA: A clue to anticancer activity of cisplatin
12. Cisplatin-DNA adducts are molecular decoys for the ribosomal RNA transcription factor hUBF (human upstream binding factor)
13. Transcription factor Y-box binding protein I binds preferentially to cisplatin-modified DNA and interacts with proliferating cell nuclear antigen
14. Cisplatin-resistant cells express increased levels of a factor that recognizes damaged DNA
15. HMG domain proteins: Architectural elements in the assembly of nucleoprotein structures
16. Specific recognition of cruciform DNA by nuclear protein HMG1
17. Cellular responses to cisplatin. The roles of DNA binding proteins and DNA repair
18. High mobility group proteins 1 and 2 function as general class II transcription factors
19. Overexpression of multidrug resistance protein gene in human cancer cell lines selected for drug resistance to epipodophyllotoxins
20. Characterisation of high-level cisplatin-resistant cell lines established from a human hepatoma cell line and human KB adenocarcinoma cells: Cross-resistance and protein changes
21. Metallothionein gene expression and resistance to cisplatin in human ovarian cancer
22. Structural and functional analysis of the human Y-box binding protein (YB-1) gene promoter
23. The role of an inverted CCAAT element in transcriptional activation of the human DNA topoisornerase IIα gene by heat shock
24. Dominant role of the second heat shock element in expression of the HSP70-1 gene in rat liver after whole body hyperthermia
25. Ligation-mediated PCR for genomic sequencing and footprinting
26. +/K+-ATPase α 1 subunit gene by in vivo footprinting
27. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
28. Characterization of an NF-1/CTF family member as a functional activator of the mouse mammary tumor virus long terminal repeat 5′ enhancer
29. The active gene that encodes human high mobility group I protein (HMGI) contains introns and maps to chromosome 13
30. In vivo footprinting and genomic sequencing by ligation-mediated PCR
31. The CCAAT-binding proteins CP1 and NF-1 cooperate with ATF-2 in the transcription of the fibronectin gene
32. Several distinct "CCAAT" box binding proteins coexist in eukaryotic cells
33. The TGGCA-binding protein: A eukaryotic nuclear protein recognizing a symmetrical sequence on double-stranded linear DNA
34. Analysis of nuclear factor I binding to DNA using degenerate oligonucleotides
35. High-affinity binding site for a specific nuclear protein in the human IgM gene
36. A family of human CCAATbox-binding proteins active in transcription and DNA replication: Cloning and expression of multiple cDNAs
37. The genes for transcription factor nuclear factor I give rise to corresponding splice variants between vertebrate species
38. Analysis of multiple forms of nuclear factor I in human and murine cell lines
39. Cisplatin inhibits chromatin remodeling, transcription factor binding, and transcription from the mouse mammary tumor virus promoter in vivo
40. Role of the human Y box-binding protein YB-1 in cellular sensitivity to the DNA-damaging agents cisplatin, mitomycin C, and ultraviolet light
41. High mobility group protein-1 (HMG-1) is a unique activator of p53